EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

J. S. Smolen, R. Landewé, F. C. Breedveld, M. Dougados, P. Emery, C. Gaujoux-Viala, S. Gorter, R. Knevel, J. Nam, M. Schoels, D. Aletaha, M. Buch, L. Gossec, T. Huizinga, J. W.J.W. Bijlsma, G. Burmester, B. Combe, M. Cutolo, C. Gabay, J. Gomez-ReinoM. Kouloumas, T. K. Kvien, E. Martin-Mola, I. McInnes, K. Pavelka, P. Van Riel, M. Scholte, D. L. Scott, T. Sokka, G. Valesini, R. Van Vollenhoven, K. L. Winthrop, J. Wong, A. Zink, D. Van Der Heijde

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)5-21
Number of pages17
JournalRevmatologiia
Volume19
Issue number1
StatePublished - Jun 20 2011

ASJC Scopus subject areas

  • Rheumatology

Cite this

Smolen, J. S., Landewé, R., Breedveld, F. C., Dougados, M., Emery, P., Gaujoux-Viala, C., Gorter, S., Knevel, R., Nam, J., Schoels, M., Aletaha, D., Buch, M., Gossec, L., Huizinga, T., Bijlsma, J. W. J. W., Burmester, G., Combe, B., Cutolo, M., Gabay, C., ... Van Der Heijde, D. (2011). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Revmatologiia, 19(1), 5-21.